Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins
- PMID: 9554870
- DOI: 10.1021/jm9708543
Anti-HIV agents that selectively target retroviral nucleocapsid protein zinc fingers without affecting cellular zinc finger proteins
Abstract
Agents that target the two highly conserved Zn fingers of the human immunodeficiency virus (HIV) nucleocapsid p7 (NCp7) protein are under development as antivirals. These agents covalently modify Zn-coordinating cysteine thiolates of the fingers, causing Zn ejection, loss of native protein structure and nucleic acid binding capacity, and disruption of virus replication. Concentrations of three antiviral agents that promoted in vitro Zn ejection from NCp7 and inhibited HIV replication did not impact the functions of cellular Zn finger proteins, including poly(ADP-ribose) polymerase and the Sp1 and GATA-1 transcription factors, nor did the compounds inhibit HeLa nuclear extract mediated transcription. Selectivity of interactions of these agents with NCp7 was supported by molecular modeling analysis which (1) identified a common saddle-shaped nucleophilic region on the surfaces of both NCp7 Zn fingers, (2) indicated a strong correspondence between computationally docked positions for the agents tested and overlap of frontier orbitals within the nucleophilic loci of the NCp7 Zn fingers, and (3) revealed selective steric exclusion of the agents from the core of the GATA-1 Zn finger. Further modeling analysis suggests that the thiolate of Cys49 in the carboxy-terminal finger is the site most susceptible to electrophilic attack. These data provide the first experimental evidence and rationale for antiviral agents that selectively target retroviral nucleocapsid protein Zn fingers.
Similar articles
-
Synthesis and biological properties of novel pyridinioalkanoyl thiolesters (PATE) as anti-HIV-1 agents that target the viral nucleocapsid protein zinc fingers.J Med Chem. 1999 Jan 14;42(1):67-86. doi: 10.1021/jm9802517. J Med Chem. 1999. PMID: 9888834
-
Binding properties of the human immunodeficiency virus type 1 nucleocapsid protein p7 to a model RNA: elucidation of the structural determinants for function.J Mol Biol. 1999 Mar 19;287(1):59-75. doi: 10.1006/jmbi.1998.2521. J Mol Biol. 1999. PMID: 10074407
-
Inhibition of HIV-1 infectivity by zinc-ejecting aromatic C-nitroso compounds.Nature. 1993 Feb 4;361(6411):473-5. doi: 10.1038/361473a0. Nature. 1993. PMID: 8429889
-
HIV-1 gag proteins: diverse functions in the virus life cycle.Virology. 1998 Nov 10;251(1):1-15. doi: 10.1006/viro.1998.9398. Virology. 1998. PMID: 9813197 Review.
-
New anti-HIV agents and targets.Med Res Rev. 2002 Nov;22(6):531-65. doi: 10.1002/med.10021. Med Res Rev. 2002. PMID: 12369088 Review.
Cited by
-
Development of a cell-based assay probing the specific interaction between the human immunodeficiency virus type 1 nucleocapsid and psi RNA in vivo.J Virol. 2007 Jun;81(11):6151-5. doi: 10.1128/JVI.00414-07. Epub 2007 Mar 14. J Virol. 2007. PMID: 17360755 Free PMC article.
-
Cysteine 155 plays an important role in the assembly of Mycobacterium tuberculosis FtsZ.Protein Sci. 2008 May;17(5):846-54. doi: 10.1110/ps.083452008. Protein Sci. 2008. PMID: 18436955 Free PMC article.
-
Preclinical evaluation of a mercaptobenzamide and its prodrug for NCp7-targeted inhibition of human immunodeficiency virus.Antiviral Res. 2016 Oct;134:216-225. doi: 10.1016/j.antiviral.2016.08.022. Epub 2016 Aug 26. Antiviral Res. 2016. PMID: 27568924 Free PMC article.
-
Cysteine-modifying agents: a possible approach for effective anticancer and antiviral drugs.Environ Health Perspect. 2002 Oct;110 Suppl 5(Suppl 5):801-6. doi: 10.1289/ehp.02110s5801. Environ Health Perspect. 2002. PMID: 12426135 Free PMC article. Review.
-
Anticancer Agents Derived from Cyclic Thiosulfonates: Structure-Reactivity and Structure-Activity Relationships.ChemMedChem. 2022 Jul 19;17(14):e202200165. doi: 10.1002/cmdc.202200165. Epub 2022 May 23. ChemMedChem. 2022. PMID: 35491396 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical